Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Back to School Savings: Save up to 30% on print books and eBooks. No promo code needed.
Back to School Savings: Save up to 30%
1st Edition - September 19, 2017
Editor: Gregory S. Makowski
Advances in Clinical Chemistry, Volume 82, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory… Read more
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Advances in Clinical Chemistry, Volume 82, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. This updated volume includes chapters on Calcium and Bone Metabolism Indices, Cytokines and MicroRNA in Coronary Artery Disease, Biological and molecular characterization of circulating tumor cells: A creative strategy for precision medicine?, Towards a blood-borne biomarker of chronic hypoxemia: Red cell distribution width and respiratory disease, miRNAs: nanomachines that microManage the pathophysiology of Diabetes mellitus, and Fortilin, A Potential Target for the Prevention and Treatment of Human Diseases.
The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.
1. Calcium and Bone Metabolism Indices
Lu Song
2. Cytokines and MicroRNA in Coronary Artery Disease
Majid Ghayour-Mobarhan
3. Biological and molecular characterization of circulating tumor cells: A creative strategy for precision medicine?
Shukun Chen
4. Towards a blood-borne biomarker of chronic hypoxemia: Red cell distribution width and respiratory disease
Joseph W. Ycas
5. miRNAs: nanomachines that microManage the pathophysiology of Diabetes mellitus
Shilpy Sharma
6. Fortilin, A Potential Target for the Prevention and Treatment of Human Diseases
Ken Fujise
GM